SQI Diagnostics

SQI Diagnostics Inc. is a life sciences company based in Toronto, Canada, specializing in the development and commercialization of proprietary multiplexing technologies for diagnostics. The company offers a range of products and services that facilitate the detection and quantification of proteins, antibodies, and DNA, including systems such as sqidworks, sqidlite, and sqid-X. These systems enable laboratories and clinical research organizations to efficiently analyze multiple biomarkers simultaneously, improving accuracy and reducing processing time. SQI Diagnostics serves various markets, including pharmaceutical and biotechnology drug development, human and animal health diagnostics, and respiratory health. The company is particularly focused on innovations in areas such as COVID-19 antibody monitoring and acute lung injury testing. Founded in 1999, SQI Diagnostics has established itself as a leader in its field, with a significant portion of its revenue generated in Canada, as well as operations in the United States and Europe.